Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 15 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
MEDIKEMOS from Ukkel, company number BE0476914059, closed financial year 2024 with a result of € 110,858 after tax. For that financial year MEDIKEMOS recorded a gross margin of € 701,932 and equity of € 431,730. Compared with financial year 2023, the result moved from € -142,641 to € 110,858. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 26, 2025.
€ 431,730
▲ 35% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 110,858
▲ still € 142,641 loss in 2023
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 411,730.
People and assets in 2024
5.6
▼ 0.5 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 309,110
▲ 29% vs 2023
€ 55,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 37,533
▼ 33% vs 2023
Of which on lease € 152.
Debts at end 2024
€ 805,504
▼ 6% vs 2023
€ 203,308 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 33,050
▼ 77% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 129,859
▼ 37% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 533,021 | € 545,024 | € 520,472 | € 701,932 | ▲ 35% |
| Profit after taxes | € 117,445 | € 24,757 | € -142,641 | € 110,858 | ▲ € 253,499 |
| Equity | € 438,755 | € 463,513 | € 320,872 | € 431,730 | ▲ 35% |
| Total debts | € 1,380,144 | € 1,264,791 | € 1,305,004 | € 1,038,104 | ▼ 20% |
| Cash | € 53,973 | € 9,018 | € 1,468 | € 0 | ▼ 100% |
| Land & buildings | € 1,593,750 | € 1,506,056 | € 1,396,399 | € 1,299,613 | ▼ 7% |
| Retained profit | € 418,755 | € 443,513 | € 300,872 | € 411,730 | ▲ 37% |
| Bank debt | € 1,049,623 | € 979,308 | € 857,629 | € 805,504 | ▼ 6% |
| Balance sheet total | € 1,818,899 | € 1,728,304 | € 1,625,876 | € 1,469,834 | ▼ 10% |
| Employees (FTE) | 3.3 | 3.3 | 6.1 | 5.6 | ▼ 0.5 |
Key figures of MEDIKEMOS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to MEDIKEMOS?
What happened at MEDIKEMOS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 110,858. filed late Source: NBB ↗
- Emorane LUPANZULA became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Ukkel. KBO
In short
From € 117,445 profit in 2021 to € 110,858 profit in 2024.
Paid € 91,667 in corporate taxes since 2021.
Best year ever: 2021, with € 117,445 profit.
On average € 125,300 of value added per employee in 2024.
A new publication or filing at MEDIKEMOS? We notify you, reason included.
Follow MEDIKEMOSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Emorane LUPANZULA
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Brugmannlaan 263 box 1A
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →YANYONG PATRIMOINE (Belgium)
€ 64,601 gross margin · 2025
GOUDSMIT & TANG BELGIUM
€ 44,819 gross margin · 2025
WORLD FUE INSTITUTE
Parabole Invest
€ 7,482 gross margin · 2025
TSUBA INVEST
€ -2,249 gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0476.914.059
- VAT number
- BE 0476.914.059
- Registered office
- Brugmannlaan 263 bus 1A, 1180 Ukkel
- Names & denominations
- MEDIKEMOS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 February 2002
- Peppol
- Active · Active since 12 Aug 2026
- Activities · NACE
Overige hospitalisatiediensten
Activiteiten van huisartspraktijken